News

Chemical and Biomolecular Engineering students have created an affordable, automated system to take the hassle out of fish tank management.

Chemical and Biomolecular Engineering students reimagine menstrual diagnostics with a product designed to improve early detection of a range of health conditions.

A team of Hopkins researchers has created an automated platform that could speed up the search for better materials for renewable energy storage. The system combines electrochemistry, artificial intelligence, and…

Johns Hopkins engineers repurpose common medications in a gel that can combat stubborn wounds.

New tool could advance research on fertility, cancer, and more.

Engineers find that adjusting fluid viscosity guides stem cells to become bone, fat, and other tissues.

Federal funding is enabling biomedical engineer Jamie Spangler and her team at Johns Hopkins to develop innovative treatments for autoimmune disorders, cancer, and other complex diseases

Johns Hopkins team takes home Best Poster Award for creating biosensors to mimic and study human tubular structures.

A team led by Hopkins engineers has developed a method to convert organic waste into medium-chain carboxylic acids (MCCAs)—crucial ingredients in industrial lubricants, bioplastics, food additives, and personal care products. The new technique offers a sustainable alternative to current MCCA production methods that pose major environmental and economic hazards, such as destroying rainforests.

Johns Hopkins engineers create responsive minuscule materials that dynamically reconfigure based on chemical signals

A team led by a Johns Hopkins doctoral candidate has developed a new technique using electricity to drive a chemical process that removes climate-damaging carbon dioxide from the air. They describe their approach, which unlike many previous electrochemical carbon capture methods operates in the presence of oxygen, in Nature Energy.

Immunoengineering research by Johns Hopkins biomedical engineers was recently featured on the cover of the journal JCI Insight. The article, “Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote…